We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $9.59B
1-Year Est. Return 113.36%
This Fund
S&P 500
This Quarter Est. Return
-10.7%
1 Year Est. Return
+113.36%
3 Year Est. Return
+277.48%
5 Year Est. Return
+350.78%
10 Year Est. Return
+2,290.11%
AUM
$2.35B
AUM Growth
-$119M
Cap. Flow
+$15.9M
Cap. Flow %
0.68%
Top 10 Hldgs %
36.4%
Holding
125
New
15
Increased
30
Reduced
16
Closed
20

Top Buys

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$76.3M
2
AVXS
AveXis, Inc. Common Stock
AVXS
+$48.9M
3
EDIT icon
Editas Medicine
EDIT
+$44.9M
4
VTRS icon
Viatris
VTRS
+$37.5M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$36M

Top Sells

Rank Stock Value
1
DYAX
DYAX CORPORATION
DYAX
+$84.3M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$53.5M
3
CRL icon
Charles River Laboratories
CRL
+$30.3M
4
GHDX
Genomic Health, Inc.
GHDX
+$28.5M
5
PCRX icon
Pacira BioSciences
PCRX
+$28.5M

Sector Composition

Rank Sector Weight
1 Healthcare 75.06%
2 Miscellaneous 20.21%
3 Financials 4.2%
4 Technology 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$228M 9.69%
13,740,261
+2,055,460
+18% +$36M
VTRS icon
2
Viatris
VTRS
$19.5B
$84.9M 3.62%
1,832,535
+776,535
+74% +$37.5M
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
$82.5M 3.51%
5,506,028
+917,028
+20% +$15.4M
GSK icon
4
GSK
GSK
$102B
$67.9M 2.89%
1,340,308
– –
AET
5
DELISTED
Aetna Inc
AET
$66.5M 2.83%
591,465
– –
PTLA
6
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$63M 2.68%
3,089,785
+2,406,036
+352% +$76.3M
AVXS
7
DELISTED
AveXis, Inc. Common Stock
AVXS
$60.9M 2.59%
+2,236,701
New +$48.9M
DVA icon
8
DaVita
DVA
$11.6B
$60.3M 2.57%
822,000
– –
EDIT icon
9
Editas Medicine
EDIT
$473M
$59M 2.51%
+1,709,400
New +$44.9M
ADPT
10
DELISTED
Adeptus Health Inc
ADPT
$53.1M 2.26%
956,533
-351,375
-27% -$18.2M
XNPT
11
DELISTED
XENOPORT, INC.
XNPT
$52.2M 2.22%
11,572,125
+5,284,751
+84% +$24.3M
VNDA icon
12
Vanda Pharmaceuticals
VNDA
$323M
$50.1M 2.13%
5,996,691
– –
GWPH
13
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$48.7M 2.07%
674,373
+364,251
+117% +$20M
XNCR icon
14
Xencor
XNCR
$1.98B
$46.5M 1.98%
3,467,512
+2,210,900
+176% +$26.2M
AAC
15
DELISTED
AAC Holdings
AAC
$45.4M 1.93%
2,294,936
+512,842
+29% +$9.71M
AVDL
16
DELISTED
Avadel Pharmaceuticals
AVDL
$45M 1.91%
4,072,809
– –
WBA
17
DELISTED
Walgreens Boots Alliance
WBA
$43.1M 1.83%
511,457
+125,000
+32% +$9.98M
UAM
18
DELISTED
Universal American Corp
UAM
$37.7M 1.61%
5,285,500
+496,473
+10% +$3.22M
SAGE
19
DELISTED
Sage Therapeutics
SAGE
$35.7M 1.52%
1,113,654
+514,800
+86% +$18.1M
AERI
20
DELISTED
Aerie Pharmaceuticals
AERI
$32M 1.36%
2,632,482
+1,824,607
+226% +$28.9M
EHTH icon
21
eHealth
EHTH
$30.4M
$30.7M 1.31%
3,264,588
– –
ZLTQ
22
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$30M 1.28%
+1,104,417
New +$26M
ARRY
23
DELISTED
Array Biopharma Inc
ARRY
$28.1M 1.2%
9,529,361
+800,000
+9% +$2.4M
FPRX
24
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$27.6M 1.18%
680,000
– –
MCK icon
25
McKesson
MCK
$107B
$27.5M 1.17%
175,000
+30,354
+21% +$4.9M
1
2 3 4 5

Similar funds

OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
MSE
MUFG Securities EMEA London, United Kingdom $9.53B AUM 52.96% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
A
Allianz Munich, Germany $9.48B AUM 23.58% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Deerfield Management's Q1 2016 Portfolio in Review

As of Q1 2016, Deerfield Management held 125 positions worth $2.35B, down 4.8% from $2.47B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Deerfield Management's Q1 2016 filing shows 15 new, 30 increased, 16 reduced and 20 closed positions. Its largest new stake was AveXis, Inc. Common Stock: 2,236,701 shares worth $60.9M. The largest sale was DYAX CORPORATION, an estimated $84.3M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, up from 74% a quarter earlier, followed by Miscellaneous and Financials.

  • Deerfield Management's largest Q1 2016 buy was AveXis, Inc. Common Stock: 2,236,701 shares worth $60.9M.
  • Deerfield Management added most to Portola Pharmaceuticals, Inc. in Q1 2016, an estimated $76.3M increase.
  • Deerfield Management's biggest Q1 2016 reduction was Adeptus Health Inc, cutting an estimated $18.2M.
  • Deerfield Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $84.3M.
  • Deerfield Management's ten largest holdings make up 36% of its $2.35B portfolio in Q1 2016.
  • Deerfield Management opened 15 new positions and closed 20 in Q1 2016.
  • Deerfield Management's portfolio value fell 4.8% quarter-over-quarter to $2.35B.

Based on Deerfield Management's 13F filing for Q1 2016, filed 16 May 2016.